Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy

Cell Death Dis. 2022 Apr 19;13(4):367. doi: 10.1038/s41419-022-04743-7.
No abstract available

Publication types

  • Published Erratum